
1 

(1) These Regulations may be cited as the Branded Health Service Medicines (Costs) (Amendment) Regulations 2023 and come into force on 1st April 2023.
(2) These Regulations extend to England and Wales, Scotland and Northern Ireland.
2 

(1) Regulation 3 (Payment scheme) of The Branded Health Service Medicines (Costs) Regulations 2018 is amended as follows.
(2) In paragraph (1), for the table substitute—“Table

Applicable Period Payment Percentage
1st April 2023 to the end of 2023 27.5%
2024 and any subsequent calendar year 27.5%”.
(3) In paragraph (1B)—
(a) for “1st July 2022 to the end of 2022” substitute “1st April 2023 to the end of 2023”,
(b) for “17.7%” substitute “28.6%”, and
(c) for “14.3%” substitute “27.5%”.
(4) In paragraph (1C)—
(a) for “1st July 2022 to the end of 2022” substitute “1st April 2023 to the end of 2023”,
(b) in sub-paragraph (a)—
(i) for “1st January 2022” substitute “1st January 2023”, and
(ii) for “30th June 2022” substitute “31st March 2023”, and
(c) in sub-paragraph (b), for “10.9%” substitute “24.4%”.
Signed by the authority of the Secretary of State for Health and Social Care
Will Quince
Minister of State,
Department of Health and Social Care
28th February 2023